antiretroviral drugs

DRUG2 trials

Sponsors

Valme University Hospital, National Institute of Allergy and Infectious Diseases (NIAID)

Conditions

HIV InfectionsHepatitis B, ChronicHepatitis C, ChronicHuman Immunodeficiency Virus

Phase 2

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

CompletedNCT03382834

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections

Start: 2018-04-26End: 2023-07-27Updated: 2024-07-03

Unknown Phase

Hepatic Safety of Currently Used Antiretroviral Regimens in Patients With Chronic Hepatitis Under Real Life Conditions

CompletedNCT01908660

Valme University HospitalHepatitis B, Chronic, Hepatitis C, Chronic, Human Immunodeficiency Virus

Start: 2007-01-31End: 2015-10-31Updated: 2015-11-11

Related Papers

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial

Clinical Infectious Diseases2022-02-1715 citations